Suggesting that the lower cost trend is likely a result of better management of chronic diseases.

The key results include the 2009 election CIGNA Fund Experience Study – Chronic Conditions: Medical cost trend was substantially less for CIGNA dial fund customers diabetes or hypertension than for individuals with one of the two diseases in traditional CIGNA health plans. Remarkably, those persons receive similar treatment regimens regardless of whether they of CDHP or HMO or PPO plans covers; suggesting that the lower cost trend is likely a result of better management of chronic diseases, but as patients forgo recommended care..

The results of the study in the 12th March issue of the journal Brain Research, a commemorative edition published in compliance with the 1,000 th published volume.Francesca O’Kane be used variety of proteins of pea and soya for their research. Upon heating the plant proteins formed a gel, from which you can might the structure of protein after heating deduce.

We are excited via receiving the the European CE approved for of our Prostatic stent delighted This success confirms the innovation and the advantages of the stent technology and takes us closer and offers the patient solutions that allow them effective and prompt treatment, ease and and comfort. Life quality, said Limor Domnitz Gishri, Chief Executive Officer from Allium Medical. alliaceous Medical have success in Europe with its bile and ureteral stent, obtain CE marking and has begun in 2007 had, and we feel that out our A stent stent is fast to need solution doctors and hospitals in Europe are. .. Stents Group Receives CE Mark Approval for its next generation Prostatic stentAllium Group, the developer of and producer of innovative stent for the urinary tract, digestive, lungs and peripheral vascular tractates, announced today that it has been CE – marking for its won prostate the stent provides commercializing system within the European Union and to to the CE marking.

Other entries from category "fitness":

Random entries